文献速递肺结节与肺癌

基于初级保健数据筛选肺癌筛查合格参与者的模型评估

Selection of eligible participants for screening for lung cancer using primary care data.
PubMed 文献 · Thorax · 2021-10-29

本研究利用英国临床实践研究数据链(CPRD)的初级保健数据,评估利物浦肺项目V.2(LLPv2)和前列腺肺结直肠卵巢(改良2012)(PLCOm2012)模型在50-80岁曾吸烟者中预测5-6年肺癌风险的表现。结果显示,两模型仅具有中等区分度(c-statistic分别为0.700和0.679),预测风险被高估,但应用风险阈值可分别避免联系42.7%和27.4%的未患肺癌者,代价是遗漏15.6%和11.4%的肺癌。结论提示风险模型可减少初筛评估人数,但需进一步改进。

要点

  • LLPv2和PLCOm2012模型在初级保健数据中区分度中等,c-statistic分别为0.700和0.679。
  • 应用1%和0.15%风险阈值可分别避免联系42.7%和27.4%的未患肺癌者。
  • 但分别会遗漏15.6%和11.4%的肺癌,需权衡利弊。

核心结论

  • 风险预测模型应用于常规初级保健数据时区分度中等,可能归因于数据质量与完整性。
  • 模型可大幅减少初筛评估人数,但会遗漏部分肺癌。
  • 需进一步研究更新模型在初级保健数据中的表现。

研究设计与样本

  • 使用临床实践研究数据链(CPRD)这一计算机化纵向初级保健数据库。
  • 评估LLPv2和PLCOm2012模型在50-80岁曾吸烟者中的表现。
  • 比较5年(LLPv2)和6年(PLCOm2012)预测风险与实际肺癌发生。

主要发现

  • 重新校准后,LLPv2的c-statistic为0.700(0.694-0.710),平均预测风险高估(预测4.61%,实际0.9%)。
  • PLCOm2012的c-statistic为0.679(0.673-0.685),预测风险为3.76%。

关键数值与推荐

  • 应用1%风险阈值(LLPv2)可避免联系42.7%的未患肺癌者,但遗漏15.6%的肺癌。
  • 应用0.15%风险阈值(PLCOm2012)可避免联系27.4%的未患肺癌者,但遗漏11.4%的肺癌。

临床怎么用

  • 在初级保健中可考虑使用风险预测模型初筛肺癌高危人群,减少不必要的联系。
  • 需注意模型预测风险高估和中等区分度,结合临床判断。

局限性

  • 模型区分度中等,可能受数据质量和完整性影响。
  • 预测风险被高估,需重新校准。
  • 可能遗漏部分肺癌病例。
  • 未评估更新模型的表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Lung cancer screening is effective if offered to people at increased risk of the disease. Currently, direct contact with potential participants is required for evaluating risk. A way to reduce the number of ineligible people contacted might be to apply risk-prediction models directly to digital primary care data, but model performance in this setting is unknown. METHOD: The Clinical Practice Research Datalink, a computerised, longitudinal primary care database, was used to evaluate the Liverpool Lung Project V.2 (LLPv2) and Prostate Lung Colorectal and Ovarian (modified 2012) (PLCOm2012) models. Lung cancer occurrence over 5-6 years was measured in ever-smokers aged 50-80 years and compared with 5-year (LLPv2) and 6-year (PLCOm2012) predicted risk. RESULTS: Over 5 and 6 years, 7123 and 7876 lung cancers occurred, respectively, from a cohort of 842 109 ever-smokers. After recalibration, LLPV2 produced a c-statistic of 0.700 (0.694-0.710), but mean predicted risk was over-estimated (predicted: 4.61%, actual: 0.9%). PLCOm2012 showed similar performance (c-statistic: 0.679 (0.673-0.685), predicted risk: 3.76%. Applying risk-thresholds of 1% (LLPv2) and 0.15% (PLCOm2012), would avoid contacting 42.7% and 27.4% of ever-smokers who did not develop lung cancer for screening eligibility assessment, at the cost of missing 15.6% and 11.4% of lung cancers. CONCLUSION: Risk-prediction models showed only moderate discrimination when applied to routinely collected primary care data, which may be explained by quality and completeness of data. However, they may substantially reduce the number of people for initial evaluation of screening eligibility, at the cost of missing some lung cancers. Further work is needed to establish whether newer models have improved performance in primary care data.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. O'Dowd EL, Ten Haaf K, Kaur J, et al. Selection of eligible participants for screening for lung cancer using primary care data. Thorax. 2021. PMID: 34716280. doi:10.1136/thoraxjnl-2021-217142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。